Antimicrob Agents Chemother
- SUDARSONO LM, Wenker SAM, Liu X, Brink J, et al
A novel hollow-fiber infection model (HFIM) for antiviral PK/PD studies of CMV
infection.
Antimicrob Agents Chemother. 2026 Jun 18:e0038126. doi: 10.1128/aac.00381.
Clin Transplant
- KLEIBOEKER HL, Descourouez JL, Saddler CM, Al-Adra D, et al
Improved Tolerability of De Novo Letermovir Over Valganciclovir for
Cytomegalovirus Prophylaxis in Seropositive Liver Transplant Recipients.
Clin Transplant. 2026;40:e70597.
J Immunol
- LEVAN J, Vaaben AV, Tsui J, Davidson BR, et al
Congenital cytomegalovirus infection drives oligoclonal expansion of cytotoxic gammadelta
T cells from early fetal progenitors.
J Immunol. 2026;215:vkag099.
J Infect Dis
- RIGGS PK, Honerkamp-Smith G, Meneses M, Caballero G, et al
CMV IgG and EBV Cell-Associated DNA Independently Associate With Veterans Aging
Cohort Study (VACS) Index 2.0 Scores in People With HIV on Antiretroviral
Therapy.
J Infect Dis. 2026 Jun 18:jiag310. doi: 10.1093.
- LICHTNER M, Vita S
CMV and EBV: a dynamic, powerful, and dangerous duo in PLWH.
J Infect Dis. 2026 Jun 18:jiag311. doi: 10.1093.
- MOMKUS J, Harris KM, Edwards JK, Yang YC, et al
A Pathogen Penalty? Associations Between Persistent Infections and Biological
Aging in the US.
J Infect Dis. 2026;233:e1320-e1329.
J Virol
- GONG S, Park D, Chung W-C, Ahn J-H, et al
Erratum for Gong et al., "Evidence for G-quadruplex-mediated transactivation by
the immediate-early 2 protein of human cytomegalovirus".
J Virol. 2026 Jun 18:e0088026. doi: 10.1128/jvi.00880.
- MCCLAVE MK, Heldwein EE
Mapping the monoclonal antibody landscape of human cytomegalovirus.
J Virol. 2026 Jun 15:e0032526. doi: 10.1128/jvi.00325.
Transplant Proc
- CABANILLA MG, Dauenhauer A, St John B
Racial and Ethnic Disparities in Cytomegalovirus Disease Progression Among Kidney
Transplant Recipients: A Single-Center Exploratory Study.
Transplant Proc. 2026 Jun 16:S0041-1345(26)00308.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016